美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Electra Therapeutics INC

9.32

+0.28003.10%

盘后：9.00-0.3199-3.43%16:32 EDT

成交量：34.67万

成交额：322.55万

市值：5.69亿

市盈率：0.00

高：9.60

开：8.99

低：8.78

收：9.04

52周最高：15.50

52周最低：8.63

股本：6,110.03万

流通股本：2,166.67万

量比：0.79

换手率：1.60%

股息：- -

股息率：- -

每股收益(TTM):-2,163.6592

每股收益(LYR):-1,408.5227

净资产收益率：--

总资产收益率：--

市净率：-2.59

市盈率(LYR):-0.01

数据加载中...

总览公司新闻资讯公告

ADARx Pharmaceuticals在扩大IPO规模后，纳斯达克首日上市股价飙升

ADARx制药公司通过规模扩大的美国首次公开募股（IPO）筹集了4.463亿美元

药物研发公司ADARx计划在美国首次公开募股（IPO）中寻求17.4亿美元的估值

随着生物技术行业势头持续，Retension Pharmaceuticals和TRex Bio相继提交美国IPO申请

免疫学药物研发公司Electra(ETRA.US)IPO定价15美元募资3.5亿今晚登陆纳斯达克

生物科技公司Electra Therapeutics(ETRA.US)IPO定价14-16美元/股拟筹资3.25亿美元

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hans/stock/ETRA/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ETRA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ETRA\",,,,,undefined,":{"symbol":"ETRA","market":"US","secType":"STK","nameCN":"Electra Therapeutics INC","latestPrice":9.32,"timestamp":1791835200000,"preClose":9.04,"halted":0,"volume":346735,"hourTrading":{"tag":"盘后","latestPrice":9.0001,"preClose":9.32,"latestTime":"16:32 EDT","volume":15120,"amount":140885.75592,"timestamp":1791837167461,"change":-0.3199,"changeRate":-0.034324,"amplitude":0.034335},"delay":0,"changeRate":0.030973451327433756,"floatShares":21666667,"shares":61100300,"eps":-2163.6592,"marketStatus":"盘后交易","change":0.28,"latestTime":"10-12 17:30:11 EDT","open":8.99,"high":9.6,"low":8.78,"amount":3225522.794865,"amplitude":0.090708,"askPrice":9.64,"askSize":100,"bidPrice":9,"bidSize":250,"shortable":3,"etf":0,"ttmEps":-2163.6592,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1791849600000},"marketStatusCode":4,"adr":0,"listingDate":1789704000000,"exchange":"NASDAQ","adjPreClose":9.04,"preHourTrading":{"tag":"盘前","latestPrice":9.22,"preClose":9.04,"latestTime":"08:39 EDT","volume":24,"amount":220.64999999999998,"timestamp":1791808759713,"change":0.18,"changeRate":0.019912,"amplitude":0.035398},"postHourTrading":{"tag":"盘后","latestPrice":9.0001,"preClose":9.32,"latestTime":"16:32 EDT","volume":15120,"amount":140885.75592,"timestamp":1791837167461,"change":-0.3199,"changeRate":-0.034324,"amplitude":0.034335},"volumeRatio":0.786474},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ETRA\",,,,,undefined,":{"symbol":"ETRA","floatShares":21666667,"roa":"--","roe":"--","lyrEps":-1408.522727,"volumeRatio":0.786474,"shares":61100300,"dividePrice":0,"high":9.6,"amplitude":0.090708,"preClose":9.04,"low":8.78,"week52Low":8.63,"pbRate":"-2.59","week52High":15.5,"institutionHeld":0,"latestPrice":9.32,"committee":0.428571,"eps":-2163.6592,"divideRate":0,"volume":346735,"delay":0,"ttmEps":-2163.6592,"open":8.99,"prevYearClose":15,"prevWeekClose":9.04,"prevMonthClose":11.25,"prevQuarterClose":11.25,"fiveDayClose":9.74,"twentyDayClose":15,"sixtyDayClose":15},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ETRA\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ETRA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ETRA\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ETRA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ETRA","date":"2026-10-09","current":-0.004308,"percent":1,"low":-10.215794,"twenty":-9.38356,"median":-8.307672,"eighty":-7.19509,"high":-6.707784,"avg":-8.300822,"sd":1.09481,"marketCap":573689968},"quantilePoints":[{"date":"2026-09-25","current":-8.674618,"twenty":-10.03966,"median":-9.724086,"eighty":-9.173666,"marketCap":741905408},{"date":"2026-10-02","current":-7.83798,"twenty":-9.778394,"median":-8.575543,"eighty":-8.297397,"marketCap":670351079},{"date":"2026-10-09","current":-6.707784,"twenty":-9.38356,"median":-8.307672,"eighty":-7.19509,"marketCap":573689968}],"updateTime":1791840611697},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ETRA\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2670266264","title":"ADARx Pharmaceuticals在扩大IPO规模后，纳斯达克首日上市股价飙升","url":"https://stock-news.laohu8.com/highlight/detail?id=2670266264","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670266264?lang=zh_cn&edition=fundamental","pubTime":"2026-09-26 00:21","pubTimestamp":1790353308,"startTime":"0","endTime":"0","summary":"更新版 2-ADARx Pharmaceuticals在扩大IPO规模后，纳斯达克首日上市股价飙升在第5、9和10段中添加了分析师评论Pragyan  Kalita路透9月25日-周五，ADARx制药公司股价较首次公开募股发行价上涨30%，此前这家处于临床后期阶段的基因疗法开发商通过扩大规模的美国IPO募集了4.463亿美元。ADARx成立于2019年，其试验性药物主要针对与免疫、肾脏、心血管和神经系统相关的疾病。自上市以来，其股价已下跌约21%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nL4S45H0W7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0395794307.EUR","LU2089984988.USD","LU2129689514.USD","LU0289961442.SGD","JDOC","LU1061106388.HKD","LU2125909593.SGD","LU1732799900.SGD","LU0029864427.USD","LU0456855351.SGD","LU2112291526.USD","ABBV","IXJ","LU0965509101.SGD","BK4581","ADRX","VHT","XLV","LU0211327993.USD","FHLC","ETRA","LU1934455863.HKD","LU1074936037.SGD","MEDX","LU0069063385.USD","SG9999015978.USD","LU1057294990.SGD","PJP","FTXH","LU0472753341.HKD","LU0689472784.USD","IE000WAW04H5.SGD","IE0004445239.USD","IE000SO60NU8.SGD","LU0661504455.SGD","LU1291159041.SGD","IE0002141913.USD","SG9999001440.SGD","TRUH","LU0310799852.SGD","IE00BVYPNW00.USD","LU1244550494.USD","LU2237443895.HKD","RXL","AGNG","LU1548497426.USD","LU2237443978.SGD","PPH","GLAM","IYH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670423354","title":"ADARx制药公司通过规模扩大的美国首次公开募股（IPO）筹集了4.463亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2670423354","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670423354?lang=zh_cn&edition=fundamental","pubTime":"2026-09-25 19:02","pubTimestamp":1790334144,"startTime":"0","endTime":"0","summary":"ADARx制药公司通过规模扩大的美国首次公开募股筹集了4.463亿美元路透9月25日-ADARx制药公司周四表示，其在美国进行的首次公开募股规模有所扩大，共筹集资金4.463亿美元，这反映出投资者对生物技术公司上市的兴趣日益浓厚。成立于2019年的ADARx，其试验性药物主要针对与免疫、肾脏、心血管及神经系统相关的疾病。ADARx表示，制药商艾伯维ABBV.N已同意在同期进行的私募配售中投资最高1亿美元，这将使其在IPO后持有约4.9%的股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nL4T45H0JH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3B42.SGD","LU0234572021.USD","VHT","LU2468319806.SGD","LU0949170772.SGD","ETRA","LU0029864427.USD","IE00BLSP4239.USD","LU0553294199.USD","LU1244550221.USD","FTXH","LU0795875169.SGD","LU1291159041.SGD","LU1496350502.SGD","AGNG","LU0882574055.USD","LU2129689514.USD","LU0256863902.USD","PJP","LU2357627491.SGD","RXL","LU0912757837.SGD","LU0708994859.HKD","IXJ","LU2237443895.HKD","LU2433249047.HKD","PPH","LU0823416689.USD","LU1074936037.SGD","ABBV","LU2129689605.HKD","IYH","LU1548497426.USD","LU2237443978.SGD","LU2237443382.USD","MEDX","ADRX","LU0861579265.USD","IE000SO60NU8.SGD","LU1934455277.USD","SG9999015986.USD","LU0432979614.USD","GLAM","JDOC","LU0198837287.USD","XLV","TRUH","LU0211328371.USD","LU1670627923.USD","FHLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669157910","title":"药物研发公司ADARx计划在美国首次公开募股（IPO）中寻求17.4亿美元的估值","url":"https://stock-news.laohu8.com/highlight/detail?id=2669157910","media":"路透中文","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669157910?lang=zh_cn&edition=fundamental","pubTime":"2026-09-21 18:32","pubTimestamp":1789986759,"startTime":"0","endTime":"0","summary":"更新版 3-药物研发公司ADARx计划在美国首次公开募股中寻求17.4亿美元的估值在第3、9和10段中添加了分析师评论Pragyan  Kalita路透9月21日-专注于开发治疗罕见病RNA药物的新药公司ADARx Pharmaceuticals周一表示，其估值目标最高可达17.4亿美元，该公司正加入一波计划在美国进行首次公开募股的生物技术公司行列。ADARx的实验性药物针对与免疫、肾脏、心血管和神经系统相关的疾病。总部位于圣地亚哥的ADARx成立于2019年，计划通过发行2190万股股票筹集最高3.719亿美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nL4S45D0ND:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4559","SG9999003800.SGD","BK4566","LU1093756168.USD","LU2129689431.USD","IE000BZT7R73.USD","ABBV","LU2237443978.SGD","PPH","RXL","BK4581","LU1023059063.AUD","LU2237443549.SGD","JDOC","LU0289961442.SGD","LU1236620750.USD","IE00BVYPNV92.GBP","LU2347655156.SGD","IE0004445239.USD","LU2433249047.HKD","LU0417517546.SGD","XLV","FTXH","LU1989772923.USD","LU0256863902.USD","ETRA","PJP","LU0708994859.HKD","LU2237443465.HKD","IE00BDGV0183.EUR","GLAM","IE00B2B36J28.USD","LU0985320562.USD","VHT","LU0689626769.HKD","LU1720051017.SGD","AGNG","TRUH","LU2133065610.SGD","IYH","BK4585","LU2357627491.SGD","LU0868494708.USD","IE00BGHQF631.EUR","MEDX","FHLC","LU0029864427.USD","LU2089283258.USD","SG9999015978.USD","IXJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668597668","title":"随着生物技术行业势头持续，Retension Pharmaceuticals和TRex Bio相继提交美国IPO申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2668597668","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668597668?lang=zh_cn&edition=fundamental","pubTime":"2026-09-19 06:35","pubTimestamp":1789770948,"startTime":"0","endTime":"0","summary":"更新版 1-随着生物技术行业势头持续，Retension Pharmaceuticals和TRex Bio相继提交美国IPO申请在第4、6-7段中补充了分析师评论路透9月18日-药物开发商Retension Pharmaceuticals和TRex Bio于上周五提交了在美国进行首次公开募股的申请文件，进一步充实了今年秋季IPO窗口期的生物技术项目储备。肯尼迪表示，鉴于Electra股价的下跌，生物科技公司的IPO将面临更严格的审查。Leerink Partners、古根海姆证券、奥本海默和Titan Partners是Retension此次发行的承销商。Retension和TRex将分别以股票代码“RTSN”和“TRXB”在纳斯达克上市。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260918:nL4S45A1QQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LLII","LU1989771016.USD","LU1868837300.USD","SG9999018857.SGD","LU0823434583.USD","LU2468319806.SGD","BK4585","LU1145028129.USD","IE0001KFT4U8.USD","BK4588","IE00B7KXQ091.USD","ELIS","BK4086","LU2108987350.USD","LU0354030511.USD","IE00BJJMRZ35.SGD","LU0823434740.USD","LU1868836914.USD","SG9999014914.USD","GDOC","LU0061475181.USD","LU2471134879.HKD","LU0889565916.HKD","LU2361044865.SGD","LU2746668974.SGD","LU1023059063.AUD","LU0203202063.USD","SG9999013999.USD","LU0320765059.SGD","LU0466842654.USD","LU1720051017.SGD","OZEM","LU2089284900.SGD","LU2491050154.USD","SGXZ51526630.SGD","SG9999018865.SGD","LU0079474960.USD","IE0002141913.USD","JDOC","LU1061106388.HKD","IXJ","IE00BJJMRX11.SGD","LU0225283273.USD","LU2111349929.HKD","LU2168563687.JPY","LU1712237335.SGD","LU1814569148.SGD","LU2456880835.USD","LU2106854487.HKD","PPH","LU1366192091.USD","LU2023250504.SGD","BK4599","VHT","LU0471298777.SGD","AGNG","LU2237443622.USD","LU0109394709.USD","LU2168564222.USD","LU2168564495.EUR","LU2462591350.SGD","IE0009355771.USD","LU0094547139.USD","IE00BKDWB100.SGD","SG9999017495.SGD","FHLC","LU2471134796.USD","IE0005OL40V9.USD","LU2552382215.SGD","LU1868837136.USD","MHIP","LU0683600562.USD","LU1974910355.USD","LU0096364046.USD","CURE","SGXZ57979304.SGD","LU0786609619.USD","IE00BFSS8Q28.SGD","BK4581","LU0787776722.HKD","LU1868836591.USD","LU0058720904.USD","LLYZ","LU0174119429.USD","LU2168564149.EUR","IE00BJJMRY28.SGD","LU2265009873.SGD","LU2471134952.CNY","XLV","LU0133085943.USD","LU2360106947.USD","LU0882574055.USD","HRTS","TMED","IE0004445015.USD","LU0689472784.USD","IE0004445239.USD","LU0256863811.USD","LU0672654240.SGD","SG9999014906.USD","SGXZ81514606.USD","LU0820561818.USD","LU2324357040.USD","LU2063271972.USD","LU0823416689.USD","LU0353189680.USD","IE00B1XK9C88.USD","RXL","PJP","SG9999001176.USD","LU0345770308.USD","SG9999014880.SGD","LU0266013472.USD","LU0456855351.SGD","LU2168564065.EUR","LU2750360641.GBP","LU1551013342.USD","GB00BDT5M118.USD","LU2461242641.AUD","LU2471134523.USD","LU0203201768.USD","LU1069344957.HKD","LU2756315664.SGD","LU1323610961.USD","LU0882574139.USD","IE00BFSS7M15.SGD","LU0198837287.USD","LU0943347566.SGD","LU0471298694.HKD","LU0234572021.USD","LU2361044949.HKD","LU0006306889.USD","LU0353189763.USD","LU1868836757.USD","LU1232071149.USD","LU2089984988.USD","BK4534","LU1057294990.SGD","LU2491050071.SGD","LU2896262040.SGD","LU2023250330.USD","LU0964807845.USD","LU0320765992.SGD","LU2237443549.SGD","MEDX","LU1720051108.HKD","LU2746668461.USD","LU0354030438.USD","IE00BFTCPJ56.SGD","LU0708995401.HKD","LU2236285917.USD","LU0385154629.USD","LU0158827781.USD","IHE","LU1267930730.SGD","SG9999001176.SGD","LU0417517546.SGD","LU0106261372.USD","LU2417539215.USD","TRUH","ILDR","SGXZ99366536.SGD","LU0345770993.USD","LU0820562030.AUD","SG9999015986.USD","LU1623119135.USD","LU2491049909.HKD","IE00BK4W5M84.HKD","CANC","LU1551013425.SGD","LU0640476718.USD","LU2237443978.SGD","WDNA","IE00BJT1NW94.SGD","SGXZ31699556.SGD","LU1064131342.USD","LU0109391861.USD","LU2112291526.USD","ETRA","LU2361045086.USD","LU2462157665.USD","LU2211815571.USD","LU2750360997.AUD","LU0114720955.EUR","IE00BWXC8680.SGD","SG9999015978.USD","TREX","LU0238689110.USD","SG9999014898.SGD","LU0256863902.USD","LU2213496289.HKD","LU2237443382.USD","IYH","LU0122379950.USD","LU1127390331.HKD","LU2028103732.USD","IE00B2B36J28.USD","LU2089283258.USD","FTXH","LU1093756168.USD","BK4533","LU2271345857.HKD","LU0316494557.USD","IE00B4JS1V06.HKD","LU2087625088.SGD","LU1548497426.USD","SG9999015945.SGD","LU0210536198.USD","LU1291159041.SGD","BK4516","LLY","IE00BK4W5L77.USD","LU0432979614.USD","BK4007","LU1691799644.USD","LU2023251221.USD","LU2602419157.SGD","IE00BN29S564.USD","MEDI","IE00BJLML261.HKD","LU0158827948.USD","LU1035775433.USD","LU0097036916.USD","LU1804176565.USD","LLYX","THNR","LU2237443895.HKD","IE00BKPKM429.USD","LU2756315318.SGD","LU2237443465.HKD","IE00B4R5TH58.HKD","LU2237438978.USD","LU2264538146.SGD","LU0289739699.SGD","LU1988902786.USD","LU1629891620.HKD","LU1983299246.USD","LU1093756325.SGD","SG9999015952.SGD","LU1979441026.SGD","IE00B1BXHZ80.USD","LU2552382058.USD","LU2552382132.HKD","LU2357305700.SGD","IE00B775H168.HKD","LU1280957306.USD","LU0323591593.USD","LU1917777945.USD","ELIL","LU0820561909.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668094871","title":"免疫学药物研发公司Electra(ETRA.US)IPO定价15美元募资3.5亿 今晚登陆纳斯达克","url":"https://stock-news.laohu8.com/highlight/detail?id=2668094871","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668094871?lang=zh_cn&edition=fundamental","pubTime":"2026-09-18 14:56","pubTimestamp":1789714618,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，临床阶段免疫学药物开发公司Electra Therapeutics Inc.通过扩大规模的美国首次公开募股募集了3.5亿美元，发行价定在推介区间的中点。Electra的主要候选药物旨在治疗继发性噬血细胞性淋巴组织细胞增生症，这是一种严重的免疫系统过度反应。本次上市恰逢药企IPO行情火热。根据文件，Electra于10月完成了约1.827亿美元的C轮融资，由法国制药商赛诺菲旗下部门、OrbiMed和Redmile领投;截至今年6月30日，公司持有9770万美元现金及现金等价物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1497857.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["ETRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667612838","title":"生物科技公司Electra Therapeutics(ETRA.US)IPO定价14-16美元/股 拟筹资3.25亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2667612838","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667612838?lang=zh_cn&edition=fundamental","pubTime":"2026-09-15 15:18","pubTimestamp":1789456715,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，专注于开发靶向SIRP抗体、用于免疫疾病和癌症治疗的II/III期的生物科技公司Electra Therapeutics周一公布了首次公开募股的发行条款。Electra Therapeutics正在开发一类精准药物，靶向特定免疫细胞群体上表达的信号调节蛋白。Electra Therapeutics欲借今年生物科技板块IPO强劲表现的东风，为其处于临床阶段的免疫介导疾病和癌症药物管线筹集资金。汇编数据显示，今年美国生物科技与制药公司的IPO累计募资额已达68亿美元，平均加权回报率接近70%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1496144.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IBBJ","ETRA","IEIH","XBI","MEDX","SYNB","LNGR","UUP","AGNG","IPOS","LENZ","BK4585","BK4139","HBImain","BK4007","UDN","BK4588","GDOC","BK4581","159837","BK4539"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":6,"code":"91000000","status":"200"}]}}